Population
Inbred mice (CBA/ca, C57BL/6, BALB/c, B10.D2)
Comparison
Synthetic peptide dimers based on epitope… vs Monomers or alternative orientations of the…
Design
Preclinical
Authors
Loading...
Hypothesis-generating for orientation-optimized peptide dimers in vaccines; human studies needed before clinical consideration.
Combining heterologous peptides with the N-terminal of the mycobacterial 65-85 sequence may be a generally applicable strategy for potentiating peptide vaccines.
Cox et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: